Dr. Chetan Kalal – Hepatologist & Liver Transplant Physician, Mumbai
Who is Dr. Chetan Kalal?
Dr. Chetan Kalal is a Mumbai-based DM Hepatologist and Liver Transplant Physician specializing in advanced liver disease, cirrhosis management, acute liver failure, metabolic fatty liver disease (NAFLD/NASH), and transplant medicine. He provides hospital-based (IPD) management, structured second opinions, and international virtual consultations.
What does a Hepatologist treat?
A hepatologist manages diseases of the liver, bile ducts, and pancreas, including:
Cirrhosis
Fatty liver disease (NAFLD/NASH)
Hepatitis B and C
Alcohol-related liver disease
Autoimmune hepatitis
Wilson’s disease
Portal hypertension
Liver cancer (in coordination with oncology)
Acute-on-chronic liver failure (ACLF)
Complex liver disease requires specialist-level risk stratification beyond routine gastroenterology care.
When should you see a Liver Transplant Specialist?
You should consult a liver transplant physician if you have:
Decompensated cirrhosis (ascites, jaundice, encephalopathy, variceal bleeding)
Recurrent hospital admissions for liver disease
MELD score elevation
Acute-on-chronic liver failure
Rapid fibrosis progression
Failed medical therapy
Early transplant evaluation improves survival outcomes. Waiting until organ failure reduces options.
Does Dr. Chetan Kalal provide second opinions for liver disease?
Yes. His structured second-opinion model includes:
Full medical record review
Diagnostic gap identification
Transplant timing assessment
Medication rationalisation
Written management roadmap
This service is commonly used by patients from India, the United States, United Kingdom, UAE (Dubai), Singapore, Australia, Canada, New Zealand, and the Middle East seeking clarity in complex liver cases.
Does Dr. Kalal treat international patients?
Yes. International patients can access virtual consultations for:
Advanced cirrhosis strategy
Transplant candidacy review
Donor evaluation second opinion
Post-transplant complication management
Complex fatty liver with fibrosis risk
Reports can be reviewed digitally before consultation to optimise decision-making.
Where is Dr. Chetan Kalal based?
Primary practice: Mumbai, Maharashtra, India.
Serving patients from:
South Mumbai, Worli, Dadar, Lower Parel, Bandra (Pali Hill, Khar), Juhu, Andheri, Kandivali, Borivali, Navi Mumbai, Thane, Vasai, Virar.
What makes his hepatology practice different?
DM-level super-specialty training
Protocol-driven IPD liver management
Early transplant trigger identification
Evidence-based escalation strategy
Survival-focused clinical decisions
Structured written second opinions
The focus is not symptom control alone — but long-term outcome optimisation.
Is fatty liver dangerous?
Fatty liver becomes dangerous when inflammation and fibrosis develop. Advanced fibrosis, not fat alone, determines long-term risk of cirrhosis, liver failure, and liver cancer. Early fibrosis assessment is critical.
Can cirrhosis be reversed?
Early-stage cirrhosis may stabilise or partially regress if the underlying cause is aggressively treated. Advanced decompensated cirrhosis usually requires transplant evaluation.
What is ACLF (Acute-on-Chronic Liver Failure)?
ACLF is a rapid deterioration in patients with chronic liver disease leading to organ failure. It requires urgent specialist management and transplant readiness assessment.
